Gameday Men’s Health Dallas, TX - Lakewood - TRT, ED, Weight Loss, and Peptide Clinic has source-ready treatment evidence for Semaglutide evidence, Tirzepatide evidence, Peptide therapy signal, PT-141 evidence, Sermorelin evidence. Confirm current medication availability, pharmacy model, and pricing before booking.
Gameday Men’s Health Dallas, TX - Lakewood - TRT, ED, Weight Loss, and Peptide Clinic
Type
Weight Loss Clinic
Location
Dallas, Texas
Starting At
Contact for Pricing
Rating
5/5 (199 reviews)
About This Provider
Gameday Men’s Health Dallas, TX - Lakewood - TRT, ED, Weight Loss, and Peptide Clinic is a weight loss clinic listed in the GLP1Search directory serving patients in Dallas, TX. Public listing data includes source-ready evidence for Semaglutide evidence, Tirzepatide evidence, Peptide therapy signal, PT-141 evidence, Sermorelin evidence; confirm current treatment availability directly with the provider.
Visit their website at gamedaymenshealth.com/lakewood-tx for the most current information on pricing, medications, and availability.
Google Reviews
Based on 199 Google reviews
Rating Distribution (estimated)
199 total reviews
Business Details
Accessibility
Payment Methods
What Patients Should Know
Before You Start
Confirm total monthly costs upfront — including membership fees, medication costs, and consultation charges. Ask about insurance coverage.
Medication Options
GLP-1 medications include Semaglutide (Ozempic/Wegovy) and Tirzepatide (Mounjaro/Zepbound). Ask which options are available and their sourcing.
Clinical Oversight
Verify your assigned clinician's credentials. Ensure regular check-ins and dose adjustments are part of the program.
Our Independence
GLP1Search does not accept referral fees. All provider data is collected independently from public sources.
Get weekly GLP-1 pricing updates
Provider comparisons, new clinic alerts, and research — delivered to your inbox.
No spam. Unsubscribe anytime.
Not sure which provider is right for you?
Every body is different. Compare pricing, medication options, pharmacy standards, and patient experiences across all 18,771 public provider records, with treatment-evidence and directory-only labels kept separate.